Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Bower: A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era.... (0.13 sec) 

A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of …

- annals.org [PDF] 
M Bower, B Gazzard, S Mandalia, T Newsom- … - Annals of internal medicine, 2005 - Am Coll Physicians
Background: The established International Prognostic Index for lymphomas has not
included patients with systemic AIDS-related non-Hodgkin lymphoma. Objective: To
establish the most appropriate prognostic index for use in patients with ...
Cited by 47 - Related articles - BL Direct - All 4 versions

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated …


M Spina, U Jaeger, JA Sparano, R Talamini, C … - Blood, 2005 - bloodjournal.hematologylibrary.org
Evidence suggests that infusional therapy is a more effective means for
administering cytotoxic therapy than intravenous bolus therapy for lymphoma and
offers greater potential for therapeutic synergy with rituximab, which has ...
Cited by 71 - Related articles - All 8 versions

Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients …

- jcojournal.org
JA Sparano, S Lee, MG Chen, T Nazeer, A … - Journal of Clinical Oncology, 2004 - jcojournal.org
PATIENTS AND METHODS: Ninety-eight assessable patients with HIV-associated
intermediate- or high-grade non-Hodgkin's lymphoma received cyclophosphamide 200
mg/m 2 /d, doxorubicin 12.5 mg/m 2 /d, and etoposide 60 mg/m 2 /d (CDE) ...
Cited by 61 - Related articles - BL Direct - All 6 versions

AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active …

- ascopubs.org
ST Lim, R Karim, BN Nathwani, A Tulpule, B … - Journal of Clinical Oncology, 2005 - jco.ascopubs.org
PATIENTS AND METHODS: Three hundred sixty-three patients with AIDS-related
lymphoma diagnosed from 1982 to 2003 were reviewed retrospectively, including
262 in the pre-HAART (HIV-BL, 117; HIV-DLCL, 145) and 101 in the HAART era ...
Cited by 64 - Related articles - All 9 versions

Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly …

- jcojournal.org
ST Lim, R Karim, A Tulpule, BN Nathwani, AM … - Journal of Clinical Oncology, 2005 - jcojournal.org
PURPOSE: To compare the prognostic factors for survival and the validity of the
International Prognostic Index (IPI) in patients with HIV-related diffuse
large-cell lymphoma (HIV-DLCL) treated with curative intent in the ...
Cited by 34 - Related articles - All 8 versions

The International Prognostic Index can be used as a guide to treatment decisions …


G Rossi, A Donisi, S Casari, A Re, GP Cadeo, … - CA A Cancer Journal for Clinicians - interscience.wiley.com
Sixty-nine consecutive evaluable patients with HIV-related systemic non-Hodgkin
lymphoma (NHL) diagnosed at a single Institution during a 10-year period were
analyzed. Primary cerebral lymphoma was not considered. Forty-nine patients ...
Cited by 52 - Related articles - BL Direct - All 3 versions

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with …

- hematologylibrary.org - Free from Publisher
RF Little, S Pittaluga, N Grant, SM Steinberg, … - Blood, 2003 - bloodjournal.hematologylibrary.org
The outcome of acquired immunodeficiency syndrome–related lymphomas (ARLs) has
improved since the era of highly active antiretroviral therapy, but median
survival remains low. We studied dose-adjusted EPOCH (etoposide, ...
Cited by 163 - Related articles - BL Direct - All 5 versions

Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or …

- bloodjournal.org
LD Kaplan, JY Lee, RF Ambinder, JA … - Blood, 2005 - Am Soc Hematology
The addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and
prednisone (CHOP) chemotherapy results in significant improvement in clinical
outcome for individuals with non–HIV-associated aggressive B-cell ...
Cited by 148 - Related articles - BL Direct - All 9 versions

Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, …

- ascopubs.org
AM Levine, A Tulpule, B Espina, A Sherrod, … - Journal of Clinical Oncology, 2004 - jco.ascopubs.org
RESULTS: Twenty-four patients were accrued. 67% had high or high-intermediate
International Prognostic Index scores; the median CD4 lymphocyte count was
112/mm 3 (range, 19/mm 3 to 791/mm 3 ). No dose-limiting toxicities were ...
Cited by 36 - Related articles - BL Direct - All 7 versions

Antiretroviral treatment regimens and immune parameters in the prevention of systemic …

- ascopubs.org
J Stebbing, B Gazzard, S Mandalia, A Teague … - Journal of Clinical Oncology, 2004 - jco.ascopubs.org
RESULTS: From this cohort of 9,621 patients, 102 have been diagnosed with
systemic AIDS-related NHL since 1996, when HAART became freely available here.
By univariate analysis, increased age, higher nadir CD4 and CD8 T-cell ...
Cited by 62 - Related articles - BL Direct - All 9 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google